<?xml encoding="utf-8" ?> Gilead Sciences GILD reported third-quarter financial results on Thursday. The transcript from the ...
Bristol Myers Squibb reported Q3 2026 revenue of $13.1 billion, increased its full-year revenue outlook and lowered non-GAAP ...
Chief Financial Officer - Lucas E. Montarce Chief Scientific and Medical Officer - Dr. Daniel Skovronsky President of Lilly ...
Welcome to the Bristol Myers Squibb Third Quarter 26 Earnings Conference Call. All participants will be in a listen-only mode ...
Bristol-Myers Squibb Company (($BMY)) has held its Q3 earnings call. Read on for the main highlights of the call. Bristol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results